子宫内膜葡萄糖转运体在胚胎着床中作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.06.1002

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (6): 1003-1007.doi: 10.16352/j.issn.1001-6325.2023.06.1002

子宫内膜葡萄糖转运体在胚胎着床中作用的研究进展

张立雪^1*, 李长兴²

1.西北民族大学医学部,甘肃兰州 730000;
2.青海大学医学院,青海西宁 810001

收稿日期:2021-06-02 修回日期:2022-07-12 出版日期:2023-06-05 发布日期:2023-05-31
通讯作者: ^*1426379458@qq.com
基金资助:
2022年度甘肃省高等学校青年博士基金(2022QB-026);2022年校级本科人才培养质量提高项目(2022XJJG-89);2022年校级创新创业教育改革项目(2022XJCXCYJGXM16)

Research progress on the role of endometrial glucose transporters in embryo implantation

ZHANG Lixue^1*, LI Changxing²

1. Department of Medicine, Northwest Minzu University, Lanzhou 730000;
2. Medical Institute of Qinghai University, Xining 810001, China

Received:2021-06-02 Revised:2022-07-12 Online:2023-06-05 Published:2023-05-31
Contact: ^*1426379458@qq.com

摘要/Abstract

摘要： 葡萄糖转运体是介导葡萄糖跨细胞膜转运的重要载体,分为易化扩散葡萄糖转运体(GLUTs)和钠-葡萄糖协同转运体(SGLTs)以及尚待深入研究的一类葡萄糖转运体SWEETS。胚胎着床过程中子宫内膜上皮细胞葡萄糖的摄取与利用可保障与着床相关功能活动得以正常运行。本文就葡萄糖转运体在胚胎着床中的作用进行阐述,旨在揭示胚胎着床的机制,为着床失败导致的女性不孕及早期流产的诊断治疗提供新的思路。

关键词: 子宫内膜, 葡萄糖转运体, 胚胎着床

Abstract: Glucose transporters are important carriers that mediate glucose transport across cell membranes, including facilitated diffusion glucose transporters (GLUTs), sodium glucose co transporters (SGLTs), and a class of glucose transporters SWEETs that have not been extensively studied. Glucose uptake and utilization of endometrial epithelial cells during implantation can ensure normal implant-related functional activities. The purpose of this paper is to elucidate the role of glucose transporter in embryo implantation in order to further reveal the mechanism of embryo implantation and provide new ideas for the diagnosis and treatment of female infertility and early abortion caused by implantation failure.

Key words: endometrium, glucose transporter, embryo implantation

中图分类号:

R339.22

张立雪, 李长兴. 子宫内膜葡萄糖转运体在胚胎着床中作用的研究进展[J]. 基础医学与临床, 2023, 43(6): 1003-1007.

ZHANG Lixue, LI Changxing. Research progress on the role of endometrial glucose transporters in embryo implantation[J]. Basic & Clinical Medicine, 2023, 43(6): 1003-1007.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2023.06.1002

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2023/V43/I6/1003

参考文献 22

[1]	Deng D, Yan N. GLUT, SGLT, and SWEET: structural and mechanistic investigations of the glucose transporters[J]. Protein Sci, 2016, 25: 546-558.
[2]	Wang H, Dey S. Roadmap to embryo implantation: clues from mouse models[J]. Nat Rev Genet, 2006, 7: 185-199.
[3]	Zhang H, Qi J, Wang Y, et al. Progesterone regulates glucose metabolism through glucose transporter 1 to promote endometrial receptivity[J]. Front Physiol, 2020, 11:543148. doi:10.3389/fphys.2020.543148.
[4]	Nie L, Zhao Y, Zhao D, et al. Progesterone-induced miR-152 interferes with embryonic implantation by downregulating GLUT3 in endometrial epithelium[J]. Am J Physiol Endocrinol Metab, 2019, 316: E557-E567.
[5]	Zhang L, Song J, Ma Y, et al. Expression of SGLT1 in the mouse endometrial epithelium and its role in early embryonic development and implantation[J]. Reprod Sci, 2021,28:3094-3108.
[6]	Long Y, Wang Y, Yuan D, et al. GLUT4 in mouse endometrial epithelium: roles in embryonic development and implantation[J]. Front Physiol, 2021, 12:674924. doi:10.3389/fphys.2021.674924.
[7]	Ma Y, Cui Z, Zhao D, et al. The effects of altered endometrial glucose homeostasis on embryo implantation in type 2 diabetic mice[J]. Reprod Sci, 2021,28:703-704.
[8]	Salker M, Singh Y, Zeng N, et al. Loss of endometrial sodium glucose cotransporter SGLT1 is detrimental to embryo survival and fetal growth in pregnancy[J]. Sci Rep, 2017, 7: 12612. doi:10.1038/s41598-017-11674-3.
[9]	Zhang X, Zhao D, Ma Y, et al. Impact of disturbed glucose homeostasis regulated by AMPK in endometrium on embryo implantation in diabetes mice[J]. Reprod Sci, 2020, 27: 1752-1757.
[10]	Girish CJ, Kotur NS, Manjunath ML. A correlative study of endometrial glycogen content and other contributory factors on female infertility[J]. International Journal of Biomedical & Advance Research, 2012, 3. doi: 10.7439/ijbar.v3i1.225.
[11]	Arhin S, Zhao J, Ji X, et al. Multiple facilitated glucose transporters SLC2As are required for normal mouse preimplantation embryo development[J]. Am J Transl Res, 2019, 11: 3412-3425.
[12]	Doblado M, Moley K. Glucose metabolism in pregnancy and embryogenesis[J]. Curr Opin Endocrinol Diabetes Obes, 2007, 14: 488-493.
[13]	Bolouki A, Zal F, Alaee S. Ameliorative effects of quercetin on the preimplantation embryos development in diabetic pregnant mice[J]. J Obstet Gynaecol Res, 2020, 46: 736-744.
[14]	KšiйanovÁ M,KovaRÍkovÁ V, ŠefCÍkovÁ Z, et al. Different response of embryos originating from control and obese mice to insulin in vitro[J]. J Reprod Dev, 2021, 67: 25-34.
[15]	Riley J, Carayannopoulos M, Wyman A, et al. Phosphatidylinositol 3-kinase activity is critical for glucose metabolism and embryo survival in murine blastocysts[J]. J Biol Chem, 2006, 281: 6010-6019.
[16]	Burkus J, Navarrete Santos A, Schindler M, et al. Adiponectin stimulates glucose uptake in mouse blastocysts and embryonic carcinoma cells[J]. Reproduction, 2020, 159: 227-239.
[17]	Chi M, Schlein A, Moley K. High insulin-like growth factor 1 (IGF-1) and insulin concentrations trigger apoptosis in the mouse blastocyst via down-regulation of the IGF-1 receptor[J]. Endocrinology, 2000, 141: 4784-4792.
[18]	Eng G, Sheridan R, Wyman A, et al. AMP kinase activation increases glucose uptake, decreases apoptosis, and improves pregnancy outcome in embryos exposed to high IGF-I concentrations[J]. Diabetes, 2007, 56: 2228-2234.
[19]	Tso L, Costello M, Albuquerque L, et al. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome[J]. Cochrane Database Syst Rev, 2020, 12: CD006105. doi:10.1002/14651858.CD006105.pub4.
[20]	Chi F, Sharppley M, Nagaraj R, et al. Glycolysis-Independent glucose metabolism distinguishes TE from ICM fate during mammalian embryogenesis[J]. Dev Cell, 2020, 53: 9-26.e4.
[21]	孙晓方,陈适,卢琳,等.糖原累积病Ⅰb型1例的临床和分子遗传分析[J].基础医学与临床,2011,31:529-533.
[22]	Belli M, Rinaudo P, Palmerini M, et al. Pre-implantation mouse embryos cultured in vitro under different oxygen concentrations show altered ultrastructures[J]. Int J Environ Res Public Health, 2020, 17. doi:10.3390/ijerph17103384.

子宫内膜葡萄糖转运体在胚胎着床中作用的研究进展

Research progress on the role of endometrial glucose transporters in embryo implantation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 22

相关文章 14

编辑推荐

Metrics

本文评价

[1]	贺晶, 李艳, 王延峰, 鲍慧. FABP4表达上调促进人子宫内膜癌细胞系HEC-1-A增殖和迁移[J]. 基础医学与临床, 2022, 42(9): 1356-1361.
[2]	李勇晓, 孙燕, 张瑞生. 丙泊酚抑制人子宫内膜癌细胞系RL95-2增殖[J]. 基础医学与临床, 2022, 42(1): 114-119.
[3]	黄博, 程苾恒, 解美婷, 刘珊汕, 魏敏. FOXM1促进子宫内膜癌细胞系HEC-1B增殖、迁移和侵袭[J]. 基础医学与临床, 2021, 41(12): 1780-1785.
[4]	邵锐锋, 何驰华, 王莹. 戊酸雌二醇改善多囊卵巢综合征大鼠氯米芬诱导的子宫内膜容受性[J]. 基础医学与临床, 2020, 40(1): 78-82.
[5]	谭细凤李怀芳王玉凤谷雨枫. 地屈孕酮联合来曲唑治疗对子宫内膜异位症患者性激素、炎性因子、CA125及VEGF的影响[J]. 基础医学与临床, 2019, 39(3): 392-395.
[6]	单莹金滢李艳王永学曾靖韩甜甜宋晓潘凌亚. 术前诊断为子宫内膜不典型增生的子宫内膜癌患者的处理[J]. 基础医学与临床, 2017, 37(4): 463-467.
[7]	张静田甜刘静崔竹梅刘元波. 表皮生长因子促进子宫内膜腺癌细胞系Ishikawa增殖[J]. 基础医学与临床, 2017, 37(4): 488-492.
[8]	谷海王伟聿郑沣唐莉. 枸橼酸氯米芬抑制大鼠子宫内膜增殖及机制[J]. 基础医学与临床, 2015, 35(8): 1049-1054.
[9]	凌康柴路维何晓茜姜蓉. ATF4基因在小鼠动情周期中子宫内膜的表达[J]. 基础医学与临床, 2014, 34(1): 78-81.
[10]	魏晓丽周远征孙爱军林姬. 孕激素治疗子宫内膜不典型增生患者的剂量选择[J]. 基础医学与临床, 2010, 30(6): 658-661.
[11]	钱素敏王蕙兰. 孕激素促子宫内膜癌细胞株凋亡及下调细胞内survivin表达[J]. 基础医学与临床, 2009, 29(8): 855-858.
[12]	郭燕红张雷邵素霞尹青龚淼张金平赵静. 雌、孕激素对LPA3在小鼠子宫内膜围着床期的表达的影响[J]. 基础医学与临床, 2009, 29(2): 178-182.
[13]	范俊董文韬孙宝治李晓林刘波王纯. 血管生成素-2和内皮抑素在子宫内膜异位症中的高表达[J]. 基础医学与临床, 2009, 29(11): 1203-1206.
[14]	范俊张师前栾少红. HOXA-11基因和妇性生殖调节[J]. 基础医学与临床, 2007, 27(4): 470-471.